Pfizer vulnerable to threat of European tariffs, CEO says
Albert Bourla, chief executive officer of Pfizer.
Pfizer is vulnerable to the possibility that President Donald Trump will place tariffs on the European Union, where the drugmaker has manufacturing plants, Chief Executive Officer Albert Bourla said.
Tariffs placed on China and the threatened tariffs on Mexico and Canada are unlikely to impact Pfizer, Bourla said in an interview at an industry conference in the US. However, the company has at least 10 plants across Europe, according to its website. Pfizer operates three plants in Ireland in Ringaskiddy, Grangecastle and Newbridge.
